ZA804680B - Pharmaceutical compositions for the prevention of tumour metastasis - Google Patents
Pharmaceutical compositions for the prevention of tumour metastasisInfo
- Publication number
- ZA804680B ZA804680B ZA00804680A ZA804680A ZA804680B ZA 804680 B ZA804680 B ZA 804680B ZA 00804680 A ZA00804680 A ZA 00804680A ZA 804680 A ZA804680 A ZA 804680A ZA 804680 B ZA804680 B ZA 804680B
- Authority
- ZA
- South Africa
- Prior art keywords
- prevention
- pharmaceutical compositions
- tumour metastasis
- tumour
- metastasis
- Prior art date
Links
- 206010027476 Metastases Diseases 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 title 1
- 230000009401 metastasis Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19792931741 DE2931741A1 (de) | 1979-08-04 | 1979-08-04 | Arzneimittel zur vermeidung von tumormetastierung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA804680B true ZA804680B (en) | 1982-04-28 |
Family
ID=6077677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA00804680A ZA804680B (en) | 1979-08-04 | 1980-08-01 | Pharmaceutical compositions for the prevention of tumour metastasis |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JPS5636452A (fr) |
| AU (1) | AU539070B2 (fr) |
| BE (1) | BE884628A (fr) |
| DE (1) | DE2931741A1 (fr) |
| IT (1) | IT1212438B (fr) |
| NZ (1) | NZ194531A (fr) |
| ZA (1) | ZA804680B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2121148A1 (fr) * | 1992-08-19 | 1994-03-03 | Otsuka Pharmaceutical Co., Ltd. | Regulateur de l'apoptose |
| US5635514A (en) * | 1994-10-25 | 1997-06-03 | G. D. Searle & Company | Heteroaralkyl and heteroarylthioalkyl thiophenolic compounds as 5-lipoxgenase inhibitors |
-
1979
- 1979-08-04 DE DE19792931741 patent/DE2931741A1/de not_active Withdrawn
-
1980
- 1980-06-30 IT IT8023121A patent/IT1212438B/it active
- 1980-08-01 AU AU61006/80A patent/AU539070B2/en not_active Ceased
- 1980-08-01 NZ NZ194531A patent/NZ194531A/en unknown
- 1980-08-01 JP JP10631980A patent/JPS5636452A/ja active Pending
- 1980-08-01 ZA ZA00804680A patent/ZA804680B/xx unknown
- 1980-08-04 BE BE0/201645A patent/BE884628A/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU6100680A (en) | 1981-02-12 |
| NZ194531A (en) | 1984-08-24 |
| AU539070B2 (en) | 1984-09-13 |
| JPS5636452A (en) | 1981-04-09 |
| BE884628A (fr) | 1981-02-04 |
| DE2931741A1 (de) | 1981-02-26 |
| IT8023121A0 (it) | 1980-06-30 |
| IT1212438B (it) | 1989-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2050828B (en) | Process for the preparations of finely divided pharmaceutical compositions | |
| PT67009A (en) | Processes for the preparation of pharmaceutical compositions | |
| GB1542848A (en) | Anti-mycotic pharmaceutical compositions containing enzymes | |
| NZ194421A (en) | 3-amino-sydnone-imines pharmaceutical compositions | |
| PH16443A (en) | Substituted tetraazetricyclic compounds and their pharmaceutical compositions | |
| ZA81136B (en) | Pharmaceutical compositions | |
| ZA805666B (en) | Pharmaceutical compositions containing paracetamol | |
| NZ189939A (en) | N-oxacyclic-alkylpiperidyl-diaza compounds pharmaceutical compositions | |
| IL59836A0 (en) | Pharmaceutical oxytetracycline compositions | |
| GB2072504B (en) | Pharmaceutical compositions | |
| IL61117A0 (en) | Acetoxymethyl-penem compounds and pharmaceutical compositions containing them | |
| GB2053230B (en) | Tripeptides of the general formula | |
| IL57476A0 (en) | Compounds of the muramy-peptide type and pharmaceutical compositions containing them | |
| GB2048671B (en) | Pharmaceutical composition containing dihydroegotoxine | |
| PT71537A (en) | Compositions of matter | |
| ZA815700B (en) | Pharmaceutical compositions | |
| DE3064666D1 (en) | Pharmaceutical compositions containing paracetamol | |
| GB2031727B (en) | Pharmaceutical compositions | |
| GB2039218B (en) | Pharmaceutical compositions | |
| PT72237A (en) | Process for the preparation of new pyrrolbenzotriazepines having pharmaceutical effect | |
| ZA804680B (en) | Pharmaceutical compositions for the prevention of tumour metastasis | |
| NZ193533A (en) | 2-isopropylamino-5-halogeno-pyrimidines pharmaceutical compositions | |
| IL60600A (en) | Pharmaceutical compositions comprising certain azolylalkenol compounds | |
| PT71885A (en) | Process for the preparation of ergot-peptide alkaloides having pharmaceutical effect | |
| ZA817684B (en) | Pharmaceutical compositions |